Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

BDX

BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 10795Held by 13 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$21.84B
Net Income FY2025
$1.68B
EPS (Basic, as reported)
$5.83
Net Margin FY2025
7.7%
ROE FY2025
6.6%
Total Equity
$25.39B
Shares Out
272M
Business description

BECTON DICKINSON & CO — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 12,483 → 21,840 +6.4% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue12,48312,09315,98317,29017,11720,24818,87019,37220,17821,840
Cost of revenue(6,492)(6,151)(8,721)(9,002)(9,540)(10,821)(10,393)(11,202)(11,053)(11,915)
Gross profit5,9915,9427,2628,2887,577—————
Research & development(828)(774)(1,006)(1,062)(1,096)(1,339)(1,256)(1,237)(1,190)(1,265)
Selling, general & administrative(3,005)(2,925)(4,015)(4,332)(4,325)(4,867)(4,709)(4,719)(4,857)(5,278)
Total operating expenses(11,053)(10,615)(14,487)(15,530)(15,633)(17,449)(16,588)(17,261)(17,780)(19,261)
Operating income1,4301,4781,4971,7601,4842,7992,2822,1112,3972,579
Interest expense(388)(521)(706)(639)(528)(469)(398)(452)(528)(613)
Interest & investment income2176651279164916338
Other income (expense), net11(57)3184323(97)(117)(46)(28)(123)
Pre-tax income1,0749761,1731,1769852,2421,7831,6622,0051,881
Income tax expense(97)(124)(862)(57)(111)(150)(148)(132)(300)(203)
Net income9761,1003111,2338742,0921,7791,4841,7051,678
EPS — basic$4.59$4.70$0.62$4.01$2.75$6.92$5.93$4.97$5.88$5.83
EPS — diluted$4.49$4.60$0.60$3.94$2.71$6.85$5.88$4.94$5.86$5.82
Shares outstanding — basic (M)213219258270279289285286290288
Shares outstanding — diluted (M)218224265275282292287288291289

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.